Adipocytokines are usually regarded as signaling molecules that originate from and act within the adipose tissue. However, recent data show that adipocytokines, especially adiponectin, exert various functions throughout the organism that are neither unambiguously protective nor solely harmful.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Body mass index influences the response to infliximab in ankylosing spondylitis
Arthritis Research & Therapy Open Access 14 May 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Laurberg, T. B. et al. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naïve compared with patients with osteoarthritis and controls. J. Rheumatol. 36, 1885–1891 (2009).
Giles, J. T., Allison, M., Bingham, C. O. 3rd & Scott, W. M. Jr. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Care Res. 61, 1248–1256 (2009).
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746–26749 (1995).
Kadowaki, T. & Yamauchi, T. Adiponectin and adiponectin receptors. Endocrine Rev. 26, 439–451 (2005).
Neumeier, M. et al. Different effects of adiponectin isoforms in human monocytic cells. J. Leukoc. Biol. 79, 803–808 (2006).
Bruun, J. M. et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am. J. Physiol. Endocrinol. Metab. 285, E527–E533 (2003).
Trujillo, M. E. & Scherer, P. E. Adiponectin—journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J. Intern. Med. 257, 167–175 (2005).
Goldstein, B. J. & Scalia, R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J. Clin. Endocrinol. Metab. 89, 2563–2568 (2004).
Ehling, A. et al. The potential of adiponectin in driving arthritis. J. Immunol. 176, 4468–4478 (2006).
Luo, X. H. et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J. Bone Miner. Res. 21, 1648–1656 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Müller-Ladner, U., Neumann, E. The multifaceted role of adiponectin in inflammatory joint disease. Nat Rev Rheumatol 5, 659–660 (2009). https://doi.org/10.1038/nrrheum.2009.232
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2009.232
This article is cited by
-
Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study
Clinical Rheumatology (2016)
-
Adiponektin als Target in der rheumatoiden Arthritis
Zeitschrift für Rheumatologie (2014)
-
Body mass index influences the response to infliximab in ankylosing spondylitis
Arthritis Research & Therapy (2012)